A modeling study published March 18, 2026 in BMC Medicine draws the clearest picture yet of fatty liver in the young. The Peking University team synthesized 56 studies on people aged 5 to 24, estimated prevalence by age, sex, and region, and projected the burden to 2050 using obesity trends. The headline is sobering: childhood MASLD is not a niche problem, it is a rising global wave.
The global pooled prevalence in 5-to-24-year-olds is 7.0 percent, with wide regional spread and a steady climb with age. In 2020, about 4.4 percent of boys aged 5 to 9 had MASLD versus 1.8 percent of girls, and by ages 20 to 24 the numbers reached 10.7 percent of young men and 4.5 percent of young women. The gap between the sexes widens with age, and both curves point upward.
The case math is the part that gets attention. Global MASLD cases in this age band rose from 119 million in 2000 to 340 million in 2020, and the model projects 434 million by 2050. Asia held the most cases in 2020, about 161 million, but Africa is projected to overtake Asia from 2040 onward as population growth and obesity converge there, reaching roughly 192 million cases by mid-century.
The risk factors are exactly what prevention would target. A higher BMI z-score carried an odds ratio of 1.81, and male sex added 1.77, which means the obesity epidemic is the engine and boys are the group carrying the most load. The authors frame obesity prevention as the core strategy, and they argue the intervention window opens in childhood, not after a scan shows damage.
The Chinese provincial analysis adds a local texture. The heaviest burdens sat in Hebei, Shandong, and Beijing in 2000, shifting to Tianjin, Shandong, and Heilongjiang after 2020, a pattern the authors read as pressure moving toward less-developed northern regions. The global story repeats at province scale: the burden lands where obesity is rising fastest and resources are thinnest.
The projection is a model, not a prophecy, and the honest read keeps that in view. The estimates lean on obesity prevalence trends, definitions of MASLD across the 56 studies varied, and the future numbers assume the obesity curve continues, which policy could bend. The value is in the direction and the scale, not the last digit of a 2050 estimate, and the authors say as much.
For parents, the practical message is earlier than most expect. Steatosis can appear in preschool years and even in utero under maternal obesity and diabetes, and the model shows prevalence climbing through the school years. That reframes the family table, vegetables, whole grains, fruit, water, and limited added sugar, as the first line of liver prevention, which is exactly the pattern this site rates friendly for every age.
The beverage angle is hard to separate from the obesity story. Sweet drinks are a concentrated source of the added sugar this site vetoes, and they feature in the childhood obesity literature the model leans on, with the sugary-drink-to-liver-fat pathway running through the same de novo lipogenesis that drives adult MASLD. Swapping sweet drinks for water is the single most reachable lever a family has.
The sex gap deserves a careful read. Boys carry higher prevalence across every age band, likely through hormonal and body-composition differences, and the model keeps that pattern through 2050. The practical takeaway is not alarm about one child but screening attention for the groups with the most load, which is how population data should guide clinics rather than panic.
The burden-shift finding has a policy edge the site can name without endorsing politics. As the disease moves toward lower-resource regions, the response has to include affordable prevention, and the cheapest prevention is the food environment, less sweet drinks, more whole foods, and room for activity. That is not a partisan claim; it is the reading of a global model that says where obesity rises, liver fat follows.
None of this replaces the clinician. The study is about population burden, not a treatment plan for any one child, and a child with concerning liver enzymes, strong obesity, or family history of liver disease needs the pediatric care team to interpret the numbers. The family table is the daily lever the parents control; the screening and the diagnosis belong to the clinic.
The modeling method is a strength worth noting. By combining meta-regression with obesity prevalence data and population projections, the study converts scattered prevalence snapshots into a coherent timeline, which is how a field moves from anecdotes to planning. The result is the kind of number that public health can build on, and the same logic explains why the site reports it with the projection caveats attached.
For a reader, the report lands as a family-scale invitation. The patterns that prevent adult fatty liver, vegetables, legumes, whole grains, fish, nuts, and water over sweet drinks, are the same patterns that keep a child off the prevalence curve, and starting young is cheaper than reversing a scan later. The model says the wave is coming; the plate is the lever that bends it, one family at a time.
The family and school table are the practical front line. Packing lunch with produce and whole grains, keeping sweet drinks as an occasion rather than a default, and building activity into the day are the childhood-scale versions of the adult advice on this site, and the model says they matter most where obesity is climbing fastest. The burden report is global, but the lever is local, one kitchen and one school at a time.
How common is MASLD in young people?
The global pooled prevalence in people aged 5 to 24 is 7.0 percent, rising with age and consistently higher in boys. In 2020 an estimated 340 million young people had it, up from 119 million in 2000.
Where is the burden shifting?
Asia had the most cases in 2020 at about 161 million, but the model projects Africa will pass Asia from 2040 onward as obesity rises there, reaching about 192 million cases by 2050. In China the burden is heaviest in the north.
What drives it?
Higher BMI z-score was the strongest risk factor, with an odds ratio of 1.81, and male sex added 1.77. The authors call obesity prevention the core strategy, and they argue for interventions that start in childhood rather than after the liver shows damage.